tau 284 has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atsumi, I; Fujii, A; Iemura, M; Kida, T; Sakai, O; Sakaki, H; Wada, T | 1 |
| Gow, JA; Klier, SM; McCue, SL; McNamara, TR; Salapatek, AM; Williams, JI | 1 |
| Kambe, N; Matsuda, H; Miyachi, Y; Nakamura, Y; Tanaka, A; Tanizaki, H | 1 |
| Lamb, BT; Ryman, D | 1 |
| Matsumoto, Y; Murata, T; Naito, K; Suzuki, T; Takata, I; Tsuzurahara, K | 1 |
| Inagaki, N; Koda, A; Nagai, H; Ueno, M | 1 |
2 review(s) available for tau 284 and Disease Models, Animal
| Article | Year |
|---|---|
Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate.
Topics: Animals; Anti-Allergic Agents; Conjunctivitis, Allergic; Disease Models, Animal; Drug Evaluation, Preclinical; Histamine Antagonists; Humans; Mice; Piperidines; Pruritus; Pyridines; Rats | 2010 |
Genetic and environmental modifiers of Alzheimer's disease phenotypes in the mouse.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Environment; Humans; Mice; Mice, Transgenic; Phenotype; Phosphorylation; Piperidines; Pyridines; tau Proteins | 2006 |
4 other study(ies) available for tau 284 and Disease Models, Animal
| Article | Year |
|---|---|
Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
Topics: Animals; Capillary Permeability; Cells, Cultured; Chemotaxis, Leukocyte; Conjunctiva; Conjunctivitis, Allergic; Disease Models, Animal; Dose-Response Relationship, Drug; Eosinophils; Guinea Pigs; Histamine; Histamine H1 Antagonists; Histamine Release; Leukotriene B4; Male; Mast Cells; Ovalbumin; Peritoneal Cavity; Piperidines; Platelet Activating Factor; Pyridines; Rats; Rats, Wistar | 2010 |
Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice.
Topics: Administration, Oral; Animals; Antipruritics; Behavior, Animal; Dermatitis, Atopic; Disease Models, Animal; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; p-Methoxy-N-methylphenethylamine; Piperidines; Pruritus; Pyridines | 2008 |
[Effect of betotastine besilate (TAU-284), a novel anti-allergic agent, on experimental allergic rhinitis].
Topics: Airway Resistance; Animals; Anti-Allergic Agents; Capillary Permeability; Disease Models, Animal; Guinea Pigs; Humans; Infant; Male; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Rhinitis, Allergic, Perennial | 1997 |
Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen.
Topics: Animals; Anti-Allergic Agents; Asthma; Bronchoconstriction; Disease Models, Animal; Eosinophilia; Eosinophils; Female; Guinea Pigs; Histamine H1 Antagonists; Hypersensitivity; Ketotifen; Male; Passive Cutaneous Anaphylaxis; Piperidines; Platelet Activating Factor; Pyridines; Rats; Rats, Wistar | 1998 |